https://www.selleckchem.com/products/ru-521.html
Significantly more men have been using combined products (24 men - 32.4%) vs. 40 women (20.6%) ( = 0.03). Regarding the drug classes in treatment of hypertension, the only significant difference was observed in the frequency of alfa-blocker use (more often in men). We did not observe any significant difference in the willingness to participate in follow-up between women and men (146, 75.3% vs. 57, 77%, respectively, = 0.45). There were no significant differences in the follow-up results. In the studied group of patients, gender did not a
Like
Comment
Share
